Phase 2 trial of sorafenib in children and young adults with refractory solid tumors: A report from the Children's Oncology Group-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Phase 2 trial of sorafenib in children and young adults with refractory solid tumors: A report from the Children's Oncology Group

Published:2015-04-27 Issue:9 Volume:62 Page:1562-1566
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr Blood Cancer

Author:

Kim AeRang¹,Widemann Brigitte C.²,Krailo Mark³,Jayaprakash Nalini²,Fox Elizabeth⁴,Weigel Brenda⁵,Blaney Susan M.⁶

Affiliation:

1. Children's National Medical Center; Washington; District of Columbia

2. Pediatric Oncology Branch; National Cancer Institute; Bethesda Maryland

3. Children's Oncology Group Statistics; Monrovia; California

4. Children's Hospital of Philadelphia; Philadelphia; Pennsylvania

5. University of Minnesota Medical Center; Minneapolis; Minnesota

6. Baylor College of Medicine; Houston; Texas

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/pbc.25548/fullpdf

Reference33 articles.

1. Discovery and development of sorafenib: A multikinase inhibitor for treating cancer;Wilhelm;Nat Rev Drug Discov,2006

2. Safety, pharmacokinetics, and preliminary antitumor activity of sorafenib: A review of four phase I trials in patients with advanced refractory solid tumors;Strumberg;Oncologist,2007

3. 2013 3 OF2

4. A phase I trial and pharmacokinetic study of sorafenib in children with refractory solid tumors or leukemias: A Children's Oncology Group Phase I Consortium report;Widemann;Clin Cancer Res,2012

5. Sorafenib in advanced clear-cell renal-cell carcinoma;Escudier;N Engl J Med,2007

Cited by 69 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Wnt/β-Catenin Signaling Pathway in Pediatric Tumors: Implications for Diagnosis and Treatment;Children;2024-06-07

2. Event‐free survival in relapsed and refractory rhabdomyosarcoma treated on cooperative group phase II trials: A report from the Children's Oncology Group;Pediatric Blood & Cancer;2024-04-16

3. Paraspinal Desmoid Tumor in a Pediatric Patient with No Surgical History: A Case Report;Asian Journal of Neurosurgery;2024-03

4. Refractory/Relapsed AML in Children and Evolution of Novel Therapies;Pediatric Oncology;2024

5. Wilms Tumor: Updates about Pathogenesis and New Possible Clinical Treatments of the Most Frequent Pediatric Urogenital Cancer: A Narrative Review;Surgeries;2023-12-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3